The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $117.58

Today's change+0.27 +0.23%
Updated May 24 10:31 AM EDT. Delayed by at least 15 minutes.
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $117.58

Today's change+0.27 +0.23%
Updated May 24 10:31 AM EDT. Delayed by at least 15 minutes.

Celgene Corp up (U.S.)$0.27

Celgene Corp is up today by (U.S.)$0.27 or 0.23% to (U.S.)$117.58. Shares have lost 1.49% over the last five days, but are unchanged over the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $117.73
  • Previous close(U.S.) $117.31
  • High(U.S.) $117.73
  • Low(U.S.) $116.97
  • Bid / Ask(U.S.) $117.58 / (U.S.) $117.59
  • YTD % change+1.58%
  • Volume488,938
  • Average volume (10-day)3,240,187
  • Average volume (1-month)3,321,824
  • Average volume (3-month)3,719,399
  • 52-week range(U.S.) $94.42 to (U.S.) $127.64
  • Beta1.84
  • Trailing P/E44.29×
  • P/E 1 year forward15.89×
  • Forward PEG0.77×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.65
Updated May 24 10:31 AM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue2,9602,9812,9832,754
Total other revenue--------
Total revenue2,9602,9812,9832,754
Gross profit2,8472,8672,8752,643
Total cost of revenue113114108111
Total operating expense1,8522,3522,6171,963
Selling / general / administrative620685698732
Research & development9951,1351,654949
Depreciation / amortization8210587175
Interest expense (income), net operating--------
Unusual expense (income)4231471-4
Other operating expenses, total--------
Operating income1,108628366792
Interest income (expense), net non-operating-136-136-137-136
Gain (loss) on sale of assets--------
Other--------
Income before tax1,025499257695
Income after tax941429171598
Income tax, total84708597
Net income941429171598
Total adjustments to net income--------
Net income before extra. items941429171598
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items941429171598
Inc. avail. to common incl. extra. items941429171598
Diluted net income941429171598
Dilution adjustment--------
Diluted weighted average shares811802802802
Diluted EPS excluding extraordinary itemsvalue per share1.160.530.210.75
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.210.870.270.74